Pricing
Pricing per document, per axis, by page volume and, for scientific review, by reference count. Price shown before validation.
EryonOne
Use cases Leaflet and SmPC
Review a patient leaflet and its SmPC
EryonOne helps compare a patient leaflet and an SmPC, both ways, when the documents are provided as main document and reference.
01 Benefits
What the tool helps check
Leaflet / SmPC consistency
Identify possible divergences between indications, posology, contraindications, warnings, interactions or adverse effects.
Patient readability
Spot complex, ambiguous or overly technical wording to prepare a rewrite by the relevant teams.
Versions and missing information
Highlight duplicates, contradictions, dosage gaps, incomplete cross-references or sections to review.
02 Use cases
When to use it
Before a submission, a variation or a documentary update.
After modifying an SmPC to prepare the patient leaflet review.
During a multi-product, multi-dosage or multilingual harmonisation.
03 Limits
EryonOne does not validate a leaflet or an SmPC
EryonOne is an assistant, not a validator. Business responsibility (regulatory, medical, quality, legal) stays with your teams. The report is working material, not an approval.
Frequently asked questions
Your questions about this use case
Can a patient leaflet be compared with an SmPC?
Yes. EryonOne can help spot discrepancies between a patient leaflet and an SmPC when both documents are provided.
Which types of discrepancies can be flagged?
Terminology, posology, contraindications, precautions, adverse effects, storage or missing information.
Does EryonOne validate a leaflet compliance?
No. The tool prepares the documentary review, but regulatory validation stays human.
Can it be used before a variation or an update?
Yes. It is a useful preparatory usage to structure the points to check before internal validation.